Pyridoxal 5'-phosphate

Physiological Role

Pyridoxal 5'-phosphate, abbreviated PLP or P5P, is the metabolically active form of vitamin B6. Once absorbed, dietary pyridoxine is converted in the liver to PLP by an enzyme that depends on zinc and riboflavin. This active form circulates bound to plasma albumin before being used by tissues.

PLP acts as a cofactor for more than 140 enzymes. It is involved in transamination, a key step in amino acid metabolism, in the decarboxylation of neurotransmitter precursors (serotonin, dopamine, GABA), and in the synthesis of heme, the core of red blood cells. These reactions affect cellular energy, mood regulation, and oxygen transport.

PLP is also a central player in the methylation cycle and one-carbon metabolism. It is the cofactor of cystathionine beta-synthase, the enzyme that converts homocysteine to cystathionine through the transsulfuration pathway. This function makes it complementary to vitamins B9 and B12 in regulating plasma homocysteine.

Reference Ranges

These reference ranges are derived from scientific literature and may differ from your laboratory's reference values.

Source : Xuan C et al. / Therapeutic Advances in Chronic Disease (NHANES 2005-2010) (2024)

Biological Significance

A PLP value in the optimal zone reflects satisfactory functional availability of vitamin B6 for the tissues. It supports amino acid transamination, neurotransmitter production, and homocysteine regulation.

A low PLP reflects suboptimal B6 status. NHANES data indicate that around a quarter of unsupplemented adults have a PLP below the commonly used threshold, without subjective signs. Low values are more frequent in older adults, oral contraceptive users, in cases of chronic inflammation, or with insufficient dietary intake.

A dose-response analysis of the NHANES cohort shows that all-cause mortality decreases gradually as PLP rises. The inflection point sits near 43 nmol/L. Above this threshold, the benefit extends to cardiovascular risk. This justifies aiming for an optimal zone rather than the mere absence of low values.

A very high PLP is most often a marker of recent vitamin B6 supplementation. It is not associated with increased risk at usual dietary or nutritional doses. Reading PLP gains accuracy when combined with homocysteine, hs-CRP, and albumin, since these markers shape its interpretation.

Influencing Factors

Diet. The richest food sources of vitamin B6 are poultry, fish (especially salmon and tuna), banana, potato, legumes, and nuts. A diet low in animal protein and minimally processed plant foods exposes to a marginal PLP.

Medications. Several molecules interfere with PLP metabolism. Isoniazid, an anti-tuberculosis drug, forms a complex with PLP that inactivates it. Hydralazine, theophylline, and some oral contraceptives can also lower plasma concentrations. A discussion with a healthcare professional is useful in case of prolonged use.

Chronic inflammation. Inflammatory markers such as hs-CRP are inversely correlated with PLP. When systemic inflammation rises, PLP is mobilized to inflammatory sites for the kynurenine pathway, which lowers its circulating level independently of dietary intake.

Physical activity. Regular exercise consumes PLP, notably through muscle glycogenolysis which requires this cofactor. Highly active individuals often have increased vitamin B6 needs.

Age. PLP status tends to decline with age, due to less efficient intestinal absorption, increased tissue consumption, and a higher prevalence of polypharmacy.

Genetics. Variants in PLP metabolism enzymes, particularly pyridoxal kinase and the phosphatases involved in its cycle, modulate the conversion between active and inactive forms.

Supplementation. Pyridoxal-5-phosphate (P5P), the directly usable bioactive form, is included in the Singular formula. Trimethylglycine, vitamin B12 as methylcobalamin, and vitamin B9 as 5-MTHF act synergistically on the methylation cycle. They may indirectly influence PLP readings.

In the Singular Formula

PLP plays a central role in personalizing the Singular formula. The formulation engine uses it to calibrate the dosage of vitamin B6 and to coordinate methylation cycle support.

When PLP falls in the very low zone, the dosage of vitamin B6 as P5P is set to its strongest level. When PLP is low, dosage is intermediate. When PLP sits in the lower part of the optimal zone, a maintenance dose is kept to preserve status. The P5P used in the formula is the active form directly usable, without prior hepatic conversion, which bypasses a step that can be limiting in some individuals.

When homocysteine is elevated or PLP is low, the engine simultaneously activates reinforced vitamin B6 support, consistent with its recognized role in normal homocysteine metabolism. This logic is completed by trimethylglycine, vitamin B9 as 5-MTHF, and vitamin B12 as methylcobalamin. These three bioactives act together on the one-carbon cycle.

A safety rule applies when albumin is low or when alkaline phosphatase is very high, since these situations make PLP interpretation more difficult. The engine then keeps a maintenance dose rather than marked supplementation. This cross-reading with homocysteine, albumin, and hs-CRP illustrates the systemic approach of Singular: a single biomarker is never read in isolation.

Scientific Studies

Frequently Asked Questions